Pyrroloquinoline quinone, commonly sold as PQQ, has a surprisingly thin side-effect profile in published research, largely because so few human trials have been conducted. Animal toxicology studies have consistently found the compound safe at doses far exceeding what any supplement delivers, and the European Food Safety Authority has formally concluded that PQQ disodium salt is safe under its intended conditions of use. That said, “few reported side effects” is not the same as “no risks,” and the gaps in the evidence matter as much as the findings themselves.
What Human Trials Actually Report
If you are hoping for a neat list of common side effects with percentages attached, the honest answer is that the data barely exist. Most published human studies on PQQ have been small, short, and focused on measuring benefits like sleep quality or cognitive markers rather than systematically tracking adverse events. A study of healthy adults given PQQ in a beverage found reductions in inflammatory markers and improvements consistent with better mitochondrial function, but the trial enrolled only ten volunteers, which is far too few to detect uncommon side effects reliably. Another study examining PQQ’s effects on stress, fatigue, and sleep reported significant improvements in sleep quality and reductions in cortisol, with no mention of notable adverse reactions at the doses used (around 20 mg per day).1Functional Foods in Health and Disease. Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep
Anecdotal reports from supplement users sometimes mention headaches, digestive discomfort, or mild nausea, but these have not been documented as statistically meaningful findings in controlled trials. The absence of evidence is not evidence of absence. Because the human evidence base is so limited, much of what we know about PQQ’s safety comes from animal studies, and those have been far more rigorous.
Animal Toxicology and the Safety Threshold
Two separate subchronic toxicity studies in rats form the backbone of PQQ’s safety case. In one study, rats received PQQ disodium salt at doses up to 400 mg per kilogram of body weight daily for 13 weeks. No deaths occurred, and researchers found no toxicologically significant changes in body weight, food intake, organ weight, or tissue appearance. The study set the no-observed-adverse-effect level at 400 mg/kg per day, which was the highest dose tested.2PubMed. A subchronic oral toxicity study on pyrroloquinoline quinone (PQQ) disodium salt in rats
A second study using a branded form of PQQ (BioPQQ) tested doses up to 100 mg/kg per day over 13 weeks. Some clinical chemistry findings and tissue changes turned up, but researchers judged them not toxicologically meaningful because the values fell within historical control ranges, were not dose-dependent, or appeared just as often in untreated animals. That study set its no-observed-adverse-effect level at 100 mg/kg per day.3Regulatory Toxicology and Pharmacology. Acute and subchronic toxicity studies of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ (TM)) in rats
To put those numbers in perspective, a typical PQQ supplement provides 10 to 20 mg per day. For an adult weighing about 70 kg, that works out to roughly 0.14 to 0.29 mg/kg per day. Even using the more conservative 100 mg/kg threshold, the European Food Safety Authority calculated a margin of exposure of 344, meaning the safe dose in animals is several hundred times higher than what humans are expected to consume. The EFSA panel concluded the supplement is safe under those conditions.4PubMed Central. Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97
Kidney Effects at High Doses
The one organ that showed sensitivity to PQQ in animal studies was the kidney, and only in female rats given high doses. In a 14-day study, high doses of PQQ led to increased relative kidney weight and associated tissue changes in female rats. A follow-up 28-day study in females also showed elevated urinary protein and the appearance of crystals in urine. Both findings reversed once dosing stopped.3Regulatory Toxicology and Pharmacology. Acute and subchronic toxicity studies of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ (TM)) in rats
A separate review confirmed these observations, noting that when rats received PQQ by injection at about 11.5 mg/kg of body weight for four consecutive days, physiological and structural changes appeared in the kidneys.5PubMed Central. Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits The injection route delivers compounds more directly than swallowing a capsule, so those findings may overstate what oral supplementation would do. Still, the pattern is worth noting: the kidneys appear to be the most sensitive target organ, at least in rodents. Whether this has any relevance at human supplement doses is unknown, but people with existing kidney conditions have good reason to be cautious and to mention PQQ use to their doctor.
The Pro-Oxidant Side of an Antioxidant
PQQ is marketed almost entirely for its antioxidant properties, so it comes as a surprise that the compound can also act as a pro-oxidant under certain conditions. Lab experiments found that PQQ caused extensive cell death in cultured cells, not because of inherent toxicity but because PQQ generated hydrogen peroxide as it reacted with components of the culture medium. When researchers added catalase, an enzyme that breaks down hydrogen peroxide, the cell-killing effect was blocked.6PubMed. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems
The researchers concluded that PQQ’s behavior depends heavily on its chemical environment: it can protect against oxidative damage in one setting and generate it in another. This is not unique to PQQ. Vitamin C, for instance, exhibits similar dual behavior depending on concentration and the presence of metal ions. For PQQ supplement users, the practical takeaway is that more is not automatically better. At typical oral doses, PQQ acts as an antioxidant in the body. Whether megadoses could tip the balance toward pro-oxidant activity in living tissue is an open question that the current evidence does not resolve.
Genotoxicity Testing
One question regulators always want answered before approving a novel food ingredient is whether it damages DNA. PQQ has been run through a standard battery of genetic toxicity tests. The Ames test, which checks for mutations in bacteria, came back negative. An in-cell chromosome test using hamster lung cells produced a weak positive result in two separate runs, which initially raised eyebrows. But when the same test was repeated using human blood cells, no genotoxic activity appeared. And in a live-animal micronucleus test, mice given PQQ at doses up to 2,000 mg/kg showed no genetic damage in their bone marrow cells. The weak lab-dish result in hamster cells was judged to have little relevance under realistic human exposure conditions.7PubMed. Genotoxicity of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ™)
A separate safety assessment of a different branded PQQ product confirmed these conclusions, finding the compound non-mutagenic in bacterial and mammalian cell tests, and non-clastogenic (meaning it did not break chromosomes) in a live-animal bone marrow test.8PubMed. Safety assessment of a novel, dietary pyrroloquinoline quinone disodium salt (mnemoPQQ(®)) In short, PQQ does not appear to pose a genetic risk.
Liver Effects Are Protective, Not Harmful
Given how many supplements carry warnings about liver stress, it is worth noting that the published evidence on PQQ points in the opposite direction. In mice genetically engineered to develop liver damage, a PQQ-supplemented diet protected against tissue death in liver cells, preserving the normal arrangement of the tissue compared to unsupplemented animals.9PubMed Central. Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice
In a model of alcohol-induced liver injury, PQQ reduced markers of liver damage, lowered liver fat accumulation, and boosted the activity of enzymes the body uses to process alcohol. The mechanism involved both enhancing the liver’s own antioxidant defenses and dampening inflammatory signaling.10Process Biochemistry. Hepatoprotective effect of pyrroloquinoline quinone against alcoholic liver injury through activating Nrf2-mediated antioxidant and inhibiting TLR4-mediated inflammation responses These are animal studies, so they do not guarantee the same effects in humans, but they suggest that PQQ at tested doses is more likely to help the liver than hurt it.
Blood Sugar Effects and Medication Concerns
Several animal studies suggest that PQQ can lower blood glucose. In diabetic mice, treatment with 40 mg/kg per day of PQQ significantly reduced blood sugar levels.11PubMed Central. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells A separate study found that PQQ at 20 mg/kg in diabetic mice markedly increased insulin levels and improved cholesterol and triglyceride profiles.12MOJ Bioequivalence & Bioavailability. Effects of pyrroloquinoline quinone and vitamin C on diabetes associated cardiac oxidative damages and hyperlipidemia in mice: biochemical and histopathological study
If you are not diabetic and you take a standard 20 mg PQQ supplement, these effects are unlikely to cause noticeable blood sugar swings. But if you take insulin or oral diabetes medications, PQQ’s glucose-lowering properties could theoretically compound those effects. No human interaction studies have been published, so the risk is speculative, but the biological plausibility is there. People managing diabetes with medication should raise PQQ supplementation with their prescriber, because stacking glucose-lowering agents without monitoring is how hypoglycemia happens.
Pregnancy and Developmental Safety
Direct human data on PQQ during pregnancy do not exist. One animal study gave PQQ to obese mice both before and after birth and found that the supplement did not affect weight gain in offspring but did increase metabolic flexibility and reduce body fat and liver fat compared to untreated pups.13FASEB Journal. Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice That sounds positive, but a single mouse study is nowhere near sufficient to establish safety in pregnant humans. Most PQQ supplement labels carry a standard warning to avoid use during pregnancy and breastfeeding, and that caution is warranted given the evidence gap.
Manufacturing Purity and What Is Actually in the Capsule
PQQ supplements are produced through bacterial fermentation, typically using a specific strain of bacterium. The EFSA assessment noted that commercial PQQ disodium salt has a minimum purity of 99%, and that batch-to-batch variability, stability, and the production process did not raise safety concerns.4PubMed Central. Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97 That assessment, however, applies to the specific branded ingredient (BioPQQ) that went through the regulatory review. The supplement market includes PQQ products from various manufacturers, and not all of them necessarily match the purity or specifications that were evaluated.
Third-party testing organizations do certify some PQQ supplements, and choosing a product with independent lab verification reduces the chance of contamination or mislabeled doses. Because the compound itself appears safe at typical doses, the practical risk for most users is less about PQQ’s inherent toxicity and more about whether the product actually contains what the label claims.
Who Should Think Twice
For most healthy adults taking 10 to 20 mg of PQQ daily, the published evidence suggests a wide safety margin. But several groups deserve a more cautious approach:
- People with kidney disease: The kidney findings in female rats, while reversible and observed at doses far above supplement levels, suggest the kidneys may be a vulnerable target organ. Until human kidney-safety data exist, extra caution is sensible.
- People on diabetes medications: PQQ’s glucose-lowering effects in animals raise the possibility of additive hypoglycemia when combined with insulin or oral glucose-lowering drugs.
- Pregnant or breastfeeding women: No human safety data exist for these populations. The single positive animal study is insufficient grounds for confidence.
- People taking high doses: The pro-oxidant behavior observed in lab conditions, the kidney effects at elevated doses in rats, and the general principle that dose makes the poison all argue against exceeding the amounts found in typical supplements without medical supervision.
How PQQ Compares to Other Mitochondrial Supplements
PQQ is often stacked with coenzyme Q10 in supplement formulations, on the theory that both support mitochondrial function through different mechanisms. An in vitro study examining PQQ and CoQ10 together in liver-derived cells found that their combined effects did not simply add up. CoQ10 alone slowed cell proliferation in the cell line tested, while PQQ alone increased it. The combination produced effects on inflammatory gene expression that differed from either compound used independently.14PubMed Central. Effects of Pyrroloquinoline Quinone (PQQ) and Coenzyme Q10 on Mitochondrial Genes, MitomiRs and Cellular Properties in HepG2 Cell Line This was a cell-culture experiment using a liver cancer cell line, so it does not translate directly to what happens in your body. But it does underscore a broader point: combining supplements is not automatically harmless, and the interactions between compounds can be unpredictable even when each one has a good individual safety record.
The supplement industry sometimes markets PQQ as if it were a well-characterized vitamin with decades of clinical data behind it. The reality is that PQQ occupies a peculiar middle ground: animal toxicology is reassuring, regulatory agencies have signed off on specific formulations, and there are no alarming signals from the small human trials that have been run. But the human evidence base remains thin enough that genuinely rare side effects could easily be hiding in the gaps. If you are healthy, taking a standard dose, and using a reputable product, the risk appears low. The honest caveat is that “appears low” reflects the limits of what has been studied, not a guarantee that every question has been answered.